Correction: Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial
Drug Research · 01.04.2023 · 73 (04) · e1
DOI: 10.1055/a-2109-9465 ↗Kurz gefasst
Korrektur in der Zeitschrift Drug Research, erschienen am 01.04.2023. Verfasst von Manouchehr Khoshbaten und 4 weiteren Autor:innen. Beteiligte Einrichtung: Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of clinical pharmacy, Faculty of pharmacy, Tabriz University of Medical, Sciences, Tabriz, Iran.
- Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
- Biotechnology Research Center, Tabriz University of Medical Sciences,Tabriz, Iran.
Zitieren
APA
Khoshbaten, M., Beheshtirouy, S., Shayanrad, S., Gharekhani, A., & Rezaee, H. (2023). Correction: Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial. Drug Research, 73(04), e1. https://doi.org/10.1055/a-2109-9465
Vancouver
Khoshbaten M, Beheshtirouy S, Shayanrad S, Gharekhani A, Rezaee H. Correction: Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial. Drug Research. 2023;73(04):e1. doi:10.1055/a-2109-9465
BibTeX
@article{Khoshbaten2023,
author = {Khoshbaten, Manouchehr and Beheshtirouy, Samineh and Shayanrad, Shahrzad and Gharekhani, Afshin and Rezaee, Haleh},
title = {Correction: Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial},
journal = {Drug Research},
year = {2023},
volume = {73},
number = {04},
pages = {e1},
doi = {10.1055/a-2109-9465}
}
EUVIMED